According to Professor Christopher Exley’s recent research, there are
currently two main aluminum adjuvants commonly used in vaccinations
today. These are AlHydrogel, a
semi-crystalline (boehmite) form of aluminium oxyhydroxide and AdjuPhos,
an amorphous salt of aluminium hydroxyphosphate. The sulphate salt of
the latter is also listed as being one component of an adjuvant system
used in vaccinations against HPV. AlHydrogel™ and AdjuPhos™ are commonly
referred to as clinically-approved aluminum adjuvants, and yet this is
not the case.
There are no
aluminum adjuvants that have been approved for intramuscular or
subcutaneous injection into humans. There are no requirements for their
approval; they are only “approved” as part of vaccine preparations.
